Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9

Laboratory Investigation

Volumn 94, Issue 11, 2014, Pages 1188-1199

  Zheng, Ying ^a,b   Qin, Zailong ^a   Ye, Qiurong ^a   Chen, Pan ^a,c   Wang, Zhen ^b   Yan, Qun ^d   Luo, Zhaohui ^a   Liu, Xiaoping ^a   Zhou, Yanhong ^a,c   Xiong, Wei ^a,c   Ma, Jian ^a,c   Li, Guiyuan ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c HUNAN CANCER HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LACTOFERRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; CCL2 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA VIRUS; DOWN REGULATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE ACTIVATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MALE; NONHUMAN; PATTERN RECOGNITION; PROTEIN PROTEIN INTERACTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; UPREGULATION;

ANTIGENS, CD14; CHEMOKINE CCL2; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-8; LACTOFERRIN; MACROPHAGES; MALE; MIDDLE AGED; NF-KAPPA B; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; UP-REGULATION;

EID: 84908478396     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.105     Document Type: Article

References (39)

1. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-768.
2. Nakamura H, Iwakiri D, Ono Y, et al. Epstein-Barr-virus-infected human T-cell line with a unique pattern of viral-gene expression. Int J Cancer 1998; 76: 587-594.
3. Savard M, Belanger C, Tardif M, et al. Infection of primary human monocytes by Epstein-Barr virus. J Virol 2000; 74: 2612-2619.
4. Savard M, Gosselin J. Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes. Virus Res 2006; 119: 134-145.
5. Fiola S, Gosselin D, Takada K, et al. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J Immunol 2010; 185: 3620-3631.
6. Gosselin J, Flamand L, D'Addario M, et al. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factoralpha. J Clin Invest 1992; 89: 1849-1856.
7. Gaudreault E, Fiola S, Olivier M, et al. Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol 2007; 81: 8016-8024.
8. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
9. Tugizov S, Herrera R, Veluppillai P, et al. Epstein-Barr virus (EBV)- infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol 2007; 81: 5484-5496.
10. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
11. Lund J, Sato A, Akira S, et al. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198: 513-520.
12. Iwakiri D, Zhou L, Samanta M, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 2009; 206: 2091-2099.
13. Legrand D, Mazurier J. A critical review of the roles of host lactoferrin in immunity. Biometals 2010; 23: 365-376.
14. Teng CT. Lactoferrin: the path from protein to gene. Biometals 2010; 23: 359-364.
15. Gonzalez-Chavez SA, Arevalo-Gallegos S, Rascon-Cruz Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents 2009; 33: 301e301-308.
16. Elass-Rochard E, Legrand D, Salmon V, et al. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun 1998; 66: 486-491.
17. Baveye S, Elass E, Fernig DG, et al. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun 2000; 68: 6519-6525.
18. Britigan BE, Lewis TS, Waldschmidt M, et al. Lactoferrin binds CpGcontaining oligonucleotides and inhibits their immunostimulatory effects on human B cells. J Immunol 2001; 167: 2921-2928.
19. Xiong W, Zeng ZY, Xia JH, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004; 64: 1972-1974.
20. Zhou Y, Zeng Z, Zhang W, et al. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogenactivated protein kinase pathway. Int J Cancer 2008; 123: 2065-2072.
21. Zheng Y, Zhang W, Ye Q, et al. Inhibition of Epstein-Barr virus infection by lactoferrin. J Innate Immun 2012; 4: 387-398.
22. Vollmer J, Krieg AM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev 2009; 61: 195-204.
23. Baumann CL, Aspalter IM, Sharif O, et al. CD14 is a coreceptor of Tolllike receptors 7 and 9. J Exp Med 2010; 207: 2689-2701.
24. Rodrigues L, Teixeira J, Schmitt F, et al. Lactoferrin and cancer disease prevention. Crit Rev Food Sci Nutr 2009; 49: 203-217.
25. Deng M, Zhang W, Tang H, et al. Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms. Oncogene 2013; 32: 4273-4283.
26. Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol 2012; 22: 144-153.
27. Yoshizaki T, Kondo S, Wakisaka N, et al. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett 2013; 337: 1-7.
28. Lei T, Yuen KS, Xu R, et al. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3∗ microRNA in nasopharyngeal carcinoma. Int J Cancer 2013; 133: 79-87.
29. Ye Y, Zhou Y, Zhang L, et al. EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma. Biochem Biophys Res Commun 2013; 436: 19-24.
30. Yoshimura T, Matsushima K, Oppenheim JJ, et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol 1987; 139: 788-793.
31. Skov L, Beurskens FJ, Zachariae CO, et al. IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis. J Immunol 2008; 181: 669-679.
32. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735-6741.
33. Lee HW, Choi HJ, Ha SJ, et al. Recruitment of monocytes/macrophages in different tumor microenvironments. Biochim Biophys Acta 2013; 1835: 170-179.
34. Negus RP, Stamp GW, Relf MG, et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 1995; 95: 2391-2396.
35. Graves DT, Barnhill R, Galanopoulos T, et al. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 1992; 140: 9-14.
36. Riethdorf L, Riethdorf S, Gutzlaff K, et al. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus- 16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am J Pathol 1996; 149: 1469-1476.
37. Ueno T, Toi M, Saji H, et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000; 6: 3282-3289.
38. Arenberg DA, Keane MP, DiGiovine B, et al. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother 2000; 49: 63-70.
39. Ohta M, Kitadai Y, Tanaka S, et al. Monocyte chemoattractant protein- 1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002; 102: 220-224.